A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt decline...

Heerspink Hiddo J. L., Cherney David, Kollaborációs szerevezet: DAPA-CKD Trial Committees and Investigators, Wittmann I., Vörös P., Dudás M., Tabak G. A., Kirschner R., Letoha Annamária, Balku I., Hermanyi Z., Zakar G., Mezei I., Nagy G. G., Lippai J., Németh A.
2021